All In Biotech

Drug Trial Radar · NCT04432376

Efficacy and Safety Study of Miconazole Oil Versus Vehicle on Fungal Infection of the Ear Canal (Otomycosis)

Randomized, Double-blind, Phase III Study of the Efficacy and Safety of Miconazole Oil Versus Vehicle Oil in the Treatment of Otomycosis, Followed by an Open-label Safety Evaluation

Last checked: Nov 19, 2026Latest source record: Jan 19, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 382 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

382

Actual

Start

Jul 8, 2020

Primary completion

Nov 1, 2021

Study completion Nov 1, 2021

Sponsor

Lead sponsor
Hill Dermaceuticals, Inc.Industry
Sponsor type
Industry
Collaborators
Abond CRO Inc.
First posted
Jun 16, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Crossover
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 7 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study involves two portions, a randomized, double-blind portion and an open-label portion, to evaluate the efficacy and safety of Miconazole oil 2% versus its Vehicle in the treatment of fungal infection of the outer ear canal (Otomycosis). The subjects randomized in the first portion of the study will have active fungal infection of the ear(s) and will be treated with either Miconazole Oil or the Vehicle for 14 days twice daily, 5 drops into the affected ear(s) per dose. The subjects enrolled in the open-label portion of the study may or may not have active fungal infection of the ear(s), and will be given the Miconazole Oil active drug following the same application of 5 drops into the ear(s) twice daily for 14 days. The intention of the study is to evaluate the efficacy of Miconazole Oil on fungal infection of the ears when applied using 5 drops into the ear(s) twice daily for 14 days continuously. This study also intends to show safety of Miconazole Oil 5 drops into each ear twice a day for 14 consecutive days.

Conditions

  • Otomycosis

Interventions

  • miconazole 2% oilDrug

    Drug treatment of otomycosis for 14 days

  • vehicle oilDrug

    Placebo treatment of otomycosis for 14 days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Subjects With Therapeutic CureTime frame: 21 days from first day of drug application

Locations

12 sites in 1 country. Site status is shown where the registry gives one.

  • Head and Neck Surgery Specialists

    Chula Vista, California

  • UCSD

    La Jolla, California

  • DaVinci Research, LLC

    Roseville, California

  • Sacramento ENT / DaVinci Research

    Sacramento, California

  • Lake ENT & FPS

    Leesburg, Florida

  • Advanced ENT & Allergy

    Louisville, Kentucky

  • DelRicht Research

    New Orleans, Louisiana

  • University of Missouri

    Columbia, Missouri

  • OnSite Clinical Solutions

    Dillon, South Carolina

  • Carolina ENT

    Orangeburg, South Carolina

  • West Houston Clinical Research Services

    Houston, Texas

  • Research Your Health

    Plano, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.